Rifadin IV NOVAPLUS
- Product NDC
- 0068-0599
- 11-digit product format
- 000680599
- Labeler code
- 0068
- Product ID
- 0068-0599_e49010b3-5685-4e9e-8e3f-18fd3ecf4539
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- rifampin
- Dosage form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAVENOUS
- Labeler
- Sanofi-Aventis U.S. LLC
- Application
- NDA050627
- Marketing category
- NDA
- Marketing start
- 2017-02-01
- Marketing end
- 0000-00-00
- Substance
- RIFAMPIN
- Active strength
- 600 mg/10mL
- Pharmacologic classes
- Rifamycin Antibacterial [EPC], Rifamycins [CS]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 0068-0599 | RIFADIN IV NOVAPLUS (RIFAMPIN) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [SANOFI-AVENTIS U.S. LLC] | 29 | Legacy NDC | 20250519_87839f65-cb33-412e-929e-564136501a84.zip |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 0068-0599-01 | 00068059901 | 1 VIAL, GLASS in 1 CARTON (0068-0599-01) > 10 mL in 1 VIAL, GLASS | 2017-02-01 | 0000-00-00 | No | No | Current |